BioCentury on BioBusiness,
Tools & Techniques
Relaxing the hyper heart
Monday, March 5, 2007
Blocking a receptor-regulating protein present in the adrenals prevents a failing heart from going into overdrive and allows it to relax and heal, according to a report in Nature Medicine by researchers at the Center for Translational Medicine at Thomas Jefferson University in Philadelphia.
The protein, called G protein-coupled receptor kinase 2 (GRK2), is responsible for the desensitization of adrenaline receptors in the heart and is essential for proper heart development. However, in heart failure, enhanced myocardial GRK2 activity is known to shut off and desensitize adrenergic receptor beta. The Thomas Jefferson researchers now have discovered there are also high levels of GRK2 in the chromaffin cells in the adrenal gland, which cause down-regulation and desensitization of adrenergic receptor alpha 2.
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2014 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial 4 Weeks of Access
Get a 4-week free trial subscription to see the important articles you are missing.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]